AROA Biosurgery Limited
Clinical trials sponsored by AROA Biosurgery Limited, explained in plain language.
A medical device company developing surgical and wound-care products from biological materials.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Sheep membrane may help cover exposed bone faster Results expected Mar 2027 (estimated)
-
Sheep membrane may help cover exposed bone faster
Disease control Recruiting nowThis study tests a special wound dressing made from sheep stomach lining, used with a vacuum device, to see if it helps cover exposed bone or tendon faster than the vacuum device alone. About 30 adults with soft tissue wounds on an arm or leg will take part. The goal is to see if…
Phase 4 • Sponsor: Aroa Biosurgery Limited • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New registry tracks Real-World use of myriad™ in wound reconstruction
Knowledge-focused Recruiting nowThis observational study follows 800 adults who receive Myriad™ during soft tissue reconstruction for wounds like abdominal dehiscence, pressure injuries, or anal fistulas. Researchers track healing time, complications, and side effects to understand how well the material works i…
Sponsor: Aroa Biosurgery Limited • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC